Transcription–replication conflicts underlie sensitivity to PARP inhibitors

Michalis Petropoulos, Angeliki Karamichali, Giacomo G. Rossetti, Alena Freudenmann, Luca G. Iacovino, Vasilis S. Dionellis, Sotirios K. Sotiriou and Thanos D. Halazonetis ()
Additional contact information
Michalis Petropoulos: University of Geneva
Angeliki Karamichali: University of Geneva
Giacomo G. Rossetti: FoRx Therapeutics AG
Alena Freudenmann: FoRx Therapeutics AG
Luca G. Iacovino: FoRx Therapeutics AG
Vasilis S. Dionellis: University of Geneva
Sotirios K. Sotiriou: FoRx Therapeutics AG
Thanos D. Halazonetis: University of Geneva

Nature, 2024, vol. 628, issue 8007, 433-441

Abstract: Abstract An important advance in cancer therapy has been the development of poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of homologous recombination (HR)-deficient cancers1–6. PARP inhibitors trap PARPs on DNA. The trapped PARPs are thought to block replisome progression, leading to formation of DNA double-strand breaks that require HR for repair7. Here we show that PARP1 functions together with TIMELESS and TIPIN to protect the replisome in early S phase from transcription–replication conflicts. Furthermore, the synthetic lethality of PARP inhibitors with HR deficiency is due to an inability to repair DNA damage caused by transcription–replication conflicts, rather than by trapped PARPs. Along these lines, inhibiting transcription elongation in early S phase rendered HR-deficient cells resistant to PARP inhibitors and depleting PARP1 by small-interfering RNA was synthetic lethal with HR deficiency. Thus, inhibiting PARP1 enzymatic activity may suffice for treatment efficacy in HR-deficient settings.

Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41586-024-07217-2 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:628:y:2024:i:8007:d:10.1038_s41586-024-07217-2

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-024-07217-2

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().